Navigation Links
Diabetes Alliance to Feature 17 Presentations for Linagliptin and Investigational Compound Empagliflozin^ During the 49th Annual Meeting of the European Association for the Study of Diabetes (EASD)
Date:9/17/2013

roblems to the Boehringer Ingelheim Drug Information Unit by calling 1-800-542-6257.

About Diabetes 
Approximately 25.8 million Americans6 and an estimated 371 million people worldwide have type 1 or type 2 diabetes.3 Type 2 diabetes is the most common type, accounting for an estimated 90 to 95 percent of all diabetes cases.4 Diabetes is a chronic condition that occurs when the body either does not properly produce, or use, the hormone insulin.5 Diabetes was estimated to cost the U.S. $245 billion in 20127.

Boehringer Ingelheim and Eli Lilly and Company 
In January 2011, Boehringer Ingelheim and Eli Lilly and Company announced an alliance in the field of diabetes that centers on three compounds representing several of the largest diabetes treatment classes. This alliance leverages the companies' strengths as two of the world's leading pharmaceutical companies, combining Boehringer Ingelheim's solid track record of research-driven innovation and Lilly's innovative research, experience, and pioneering history in diabetes. By joining forces, the companies demonstrate commitment in the care of patients with diabetes and stand together to focus on patient needs. Find out more about the alliance at www.boehringer-ingelheim.com or www.lilly.com.

About Boehringer Ingelheim 
Boehringer Ingelheim Pharmaceuticals, Inc., based in Ridgefield, CT, is the largest U.S. subsidiary of Boehringer Ingelheim Corporation (Ridgefield, CT) and a member of the Boehringer Ingelheim group of companies.

The Boehringer Ingelheim group is one of the world's 20 leading pharmaceutical companies. Headquartered in Ingelheim, Germany, it operates globally with 140 affiliates and more than 46,000 employees. Since it was founded in
'/>"/>

SOURCE Eli Lilly and Company; Boehringer Ingelheim
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. Lexicon Receives Funding for Phase 2 Clinical Trial of LX4211 in Type 1 Diabetes
2. Lilly Sets Date for Lilly Diabetes Pipeline Update to the Investment Community
3. Islet Sciences Announces Exclusive License Agreement with Yale University to Commercialize an Early Beta Cell Destruction and Diabetes Diagnostic
4. CASiGEN Pharma Receives A World-wide Exclusive License From GIBH To Bring New Potential Diabetes Treatments To The Global Market
5. Lilly Diabetes Presents Phase II Blood Pressure and Heart Rate Data on Investigational GLP-1 Analog Candidate, Dulaglutide, in Patients with Type 2 Diabetes at the 27th American Society of Hypertension Scientific Meeting
6. Valeritas Inc. Selects dLifes New Diabetes Patient Engagement Solution For Valeritas V-go Disposable Insulin Delivery Device
7. Jentadueto® (linagliptin/metformin hydrochloride) tablets recommended for approval in the treatment of adults with type 2 diabetes in Europe
8. Janssen Research & Development Submits New Drug Application to U.S. FDA for Canagliflozin to Treat Patients with Type 2 Diabetes
9. JDRF and BD Collaborate to Develop More Accurate and Reliable Glucose Monitoring Devices for People with Type 1 Diabetes
10. Eleven Integrated Health Systems Form Largest Private-Sector Diabetes Registry in United States
11. Lexicon Presents Data Regarding the Mechanism of Action and Safety of LX4211 at American Diabetes Association Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/7/2015)... July 7, 2015   Decision Resources Group ... in dialysis patient management in the U.S. versus ... by U.S. and EU5 nephrologists from approximately 1,870 ... are the most commonly used renal medications in ... differs considerably between the two regions.      ...
(Date:7/7/2015)... FRANCISCO , July 7, 2015 ... reach USD 1,197.7 million by 2020, growing at an estimated ... new study by Grand View Research, Inc. Introduction of innovative ... coupled with growing awareness levels pertaining to the advantages of ... the next six years. In addition, presence of untapped growth ...
(Date:7/7/2015)... , July 7, 2015 EnteroMedics Inc. ... devices that use neuroblocking technology to treat obesity, metabolic ... its previously announced public offering of 32,000,000 units. Each unit ... Series A warrant to purchase one share of common ... Investors whose purchase of units in the offering would ...
Breaking Medicine Technology:Similarities And Differences Exist When Comparing U.S. Versus EU5 Dialysis Patient Management 2Similarities And Differences Exist When Comparing U.S. Versus EU5 Dialysis Patient Management 3Breast Pumps Market To Reach $1,197.7 Million By 2020: Grand View Research, Inc. 2Breast Pumps Market To Reach $1,197.7 Million By 2020: Grand View Research, Inc. 3Breast Pumps Market To Reach $1,197.7 Million By 2020: Grand View Research, Inc. 4EnteroMedics Inc. Announces Pricing of $16.0 Million Public Offering of Common Stock and Warrants 2EnteroMedics Inc. Announces Pricing of $16.0 Million Public Offering of Common Stock and Warrants 3
... CHICAGO and ORANGE, Calif., Feb. 23, 2011 ... (SJHS), a $4.6 billion not-for-profit Catholic healthcare system based in ... in California, West Texas and Eastern New Mexico, has selected ... MDRX ) to streamline patient movement through their ...
... Caliper Life Sciences, Inc. (Nasdaq: ... announced a co-marketing agreement which will leverage Covaris, ... microfluidics technologies to develop automated workflows for next ... suite of solutions for library construction, sample analysis, ...
Cached Medicine Technology:St. Joseph Health System Selects Allscripts Care Management and Homecare Solutions 2St. Joseph Health System Selects Allscripts Care Management and Homecare Solutions 3St. Joseph Health System Selects Allscripts Care Management and Homecare Solutions 4St. Joseph Health System Selects Allscripts Care Management and Homecare Solutions 5Caliper and Covaris Establish Co-Marketing Agreement to Simplify Next Generation Sequencing 2Caliper and Covaris Establish Co-Marketing Agreement to Simplify Next Generation Sequencing 3
(Date:7/7/2015)... ... July 07, 2015 , ... The plastic ... mark on the cosmetic surgery industry with its commitment, teamwork, and dedication — ... partnered medical provider is committed to patient safety, world-class results, and compassionate care. ...
(Date:7/7/2015)... ... July 07, 2015 , ... Difass USA, a modern supplement brand committed ... stressful days at work is knowing that there is hopefully a vacation to look ... free as imagined. Planning for a vacation can be quite stressful, and it’s difficult ...
(Date:7/7/2015)... ... July 07, 2015 , ... The United States Centers for ... of Massachusetts , and the Multicultural AIDS Coalition $3.78 million for a ... have sex with men (MSM) and transgender women, the groups at highest risk ...
(Date:7/7/2015)... ... 2015 , ... SC&H Group, a leading audit, tax, and consulting firm, recently ... community through company-wide volunteering efforts. , On an annual basis, in coordination with ... in need throughout Baltimore and Washington D.C. , This year, SC&H Group’s ...
(Date:7/7/2015)... ... July 07, 2015 , ... The Immune Deficiency Foundation ... patient community using its IDF ePHR, an electronic personal health record powered by ... to easily track their health information, including symptoms, diagnoses, medications, infusions and other ...
Breaking Medicine News(10 mins):Health News:Top Plastic Surgery Provider in Brazil Joins VisitandCare.com 2Health News:Top Plastic Surgery Provider in Brazil Joins VisitandCare.com 3Health News:Difass USA Offers Eight Tips to Help Relax and Enjoy Summer Vacation 2Health News:Difass USA Offers Eight Tips to Help Relax and Enjoy Summer Vacation 3Health News:CDC Awards Fenway Health, AIDS Action, Multicultural AIDS Coalition $3.78m For ‘Getting To Zero’ HIV Prevention Partnership 2Health News:CDC Awards Fenway Health, AIDS Action, Multicultural AIDS Coalition $3.78m For ‘Getting To Zero’ HIV Prevention Partnership 3Health News:SC&H Group Celebrates 9th Annual Day of Service 2Health News:Get Real Health Launches New Mobile App for Immune Deficiency Foundation Patient Community 2Health News:Get Real Health Launches New Mobile App for Immune Deficiency Foundation Patient Community 3
... ... a symptom of cancer rather than a cause.,• Possible benefit of higher HDL and cancer ... ... Association for Cancer Research hosted a press briefing on this study on Tuesday, Nov. 3, ...
... half of those with lung disease symptoms remain undiagnosed, experts ... Americans are aware of chronic obstructive pulmonary disease (COPD), but ... be treated, according to national survey results released this week ... Month in November. , COPD affects 20 percent of U.S. ...
... , ... of the US Food and Drug Administration (FDA), will deliver the opening keynote address to ... (DIA) 46th Annual Meeting. , ... Horsham, PA (Vocus) November 4, 2009 -- Dr. Margaret Hamburg, Commissioner of the ...
... , ... BibsToGo.com launches a line of disposable, recyclable and customizable bibs to help keep both children ... Video Solutions of Rye, NY. , ... ,Dix Hills, NY (PRWEB) November 4, 2009 -- Andre Muller is a ...
... In order to help millions of Americans ... conditions, depression and obesity, the Neutraceutical Company, LLC ... the ability to address both issues safely and ... brand, has clinically established a remarkable success in ...
... Jude Children,s Research Hospital launched the sixth annual Thanks ... retail and corporate partners that ask consumers to "Give thanks ... those who are not." The announcement was made today by ... , For the first time, GRAMMY® Award-nominated singer and ...
Cached Medicine News:Health News:Cholesterol and Cancer: Answers and Some New Questions 2Health News:Cholesterol and Cancer: Answers and Some New Questions 3Health News:Cholesterol and Cancer: Answers and Some New Questions 4Health News:Cholesterol and Cancer: Answers and Some New Questions 5Health News:Americans Gaining Awareness of COPD: Survey 2Health News:FDA Commissioner Margaret Hamburg to Deliver Keynote Address at DIA 46th Annual Meeting, June 13-17, 2010 in Washington, DC , 2Health News:FDA Commissioner Margaret Hamburg to Deliver Keynote Address at DIA 46th Annual Meeting, June 13-17, 2010 in Washington, DC , 3Health News:BibsToGo.com Answers: How Can a Traditional Baby Product Help Corporate America Look Better? 2Health News:New Product Launch - SAFFRENE Delivers Impressive Mood Elevation and Weight-loss Benefits 2Health News:Stars of Film, Television, Sports and Music Join Marlo Thomas to Kick Off the 6th Annual Thanks and Giving(R) Campaign to Support St. Jude Children's Research Hospital(R) 2Health News:Stars of Film, Television, Sports and Music Join Marlo Thomas to Kick Off the 6th Annual Thanks and Giving(R) Campaign to Support St. Jude Children's Research Hospital(R) 3Health News:Stars of Film, Television, Sports and Music Join Marlo Thomas to Kick Off the 6th Annual Thanks and Giving(R) Campaign to Support St. Jude Children's Research Hospital(R) 4Health News:Stars of Film, Television, Sports and Music Join Marlo Thomas to Kick Off the 6th Annual Thanks and Giving(R) Campaign to Support St. Jude Children's Research Hospital(R) 5
... Practice management software for ... a true multi-tasking, multi-office practice ... in database technology- Winx Pro ... will assist you in effectively ...
The XT-1800i is a compact, high performance, automated hematology analyzer that provides accurate and precise CBC result including a fully automated WBC 5-part differential, and comprehensive test re...
The SE-9000 automated hematology analyzer provides accurate and precise CBC result including a fully automated WBC 5-part differential, and comprehensive test results for enhanced screening ability....
... offers three-dimensional VCS technology, ... and efficiency in white ... analysis. With its reputation ... HmX is an affordable ...
Medicine Products: